GlassScriptPhysician profile
Thomas J Myers
NPI 1881973956
$118,307.54
in general payments reported to CMS, 2019-2025
52 companies · $4,584 in 2025
The $4,584 reported for 2025 was more than what 92% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $18K · 2021: $21K · 2022: $6,023 · 2023: $37K · 2024: $30K · 2025: $4,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Consulting Fee: $13K · Travel and Lodging: $8,769 · Food and Beverage: $5,885 · Education: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,945.00 |
| Consulting Fee | $13,035.00 |
| Travel and Lodging | $8,769.48 |
| Food and Beverage | $5,885.35 |
| Education | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $78,612.80 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, General - Therapies |
| Spr Therapeutics, INC | $15,972.77 | 2022-2025 | Sprint Pns System |
| Spinal Simplicity, LLC | $9,190.29 | 2021-2024 | Ha Minuteman G3-R |
| Foundation Fusion Solutions, LLC | $6,034.67 | 2021-2023 | |
| Medtronic, INC. | $4,275.88 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $1,092.06 | 2020-2023 | Intracept |
| Abbott Laboratories | $579.79 | 2021-2024 | Eterna |
| Vertiflex, INC. | $493.66 | 2019 | |
| Nalu Medical, INC. | $424.10 | 2021-2024 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $137.45 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $130.38 | 2022-2023 | Austedo Xr, Austedo |
| Pfizer INC. | $120.02 | 2019-2023 | |
| Vertos Medical, INC. | $95.15 | 2021 | |
| Pacira Therapeutics, INC. | $91.68 | 2019-2020 | |
| Abbvie INC. | $88.28 | 2021-2023 |
Show all 51 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.